Compare GoPro Inc (GPRO) vs Medpace Holdings Inc (MEDP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GoPro Inc vs Medpace Holdings Inc — how do they compare? GoPro Inc trades at $1.19 (market cap $243.50M), while Medpace Holdings Inc trades at $614.17 (market cap $16.82B). The key difference: Medpace Holdings Inc is far larger — about 69.1× GoPro Inc's market cap, and Medpace Holdings Inc is trading nearer its 52-week high, GoPro Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold GoPro Inc for 45 Days and Medpace Holdings Inc for 14 Days on average.
| GPRO | MEDP | |
|---|---|---|
Market Cap | $243.50M | $16.82B |
Volume | 11,527,160 | 223,093 |
Sector | Technology | Health |
52-Week High | $2.35 | $630.19 |
52-Week Low | $0.58 | $393.42 |
Typical Hold Time | 45 Days | 14 Days |
Enterprise Value | $302.28M | $16.44B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GoPro (GPRO) trades at $1.20, down 1.64% with a volatile trading pattern following recent merger announcements. The stock shows bullish technical signals despite negative fundamental metrics including a -28.52% net income margin and -497.15% ROE. Recent developments include a $285 million merger agreement with Starman Optical and significant retail investor interest from influencer Markiplier's 8.5% stake acquisition.
The proposed merger at $1.14 per share creates a potential exit opportunity, though current trading above this level suggests market optimism about deal terms. However, persistent negative cash flows, declining revenues, and shareholder litigation regarding deal fairness present substantial risks. The company's pivot into AI data centers offers growth potential but execution uncertainty remains high.
Medpace (MEDP) trades at $617.47, up 2.19% with strong quarterly earnings beats and robust profitability metrics. The stock shows neutral technical signals with key resistance at $620, while fundamentals reveal impressive ROE of 162.15% and consistent revenue growth to $2.8B projected for 2026. Recent CEO stock sales and mixed institutional activity create balanced sentiment ahead of Q3 earnings announcement on October 21, 2026.
MEDP presents growth potential with analyst consensus target of $620.44 and strong historical execution, though elevated valuations (P/E 35.41) and insider selling warrant caution. The stock's upside depends on continued earnings delivery amid competitive medical services landscape.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About GoPro Inc
GoPro Inc is a United States-based company that is principally engaged in designing and providing cameras, mounts, drones and appliances. The company outsources a part of manufacturing to third parties in China. The company sells products across the world through its direct sales channel, which generates over half of total revenue, and indirectly through its distribution channel. The company has presence, including in the Americas, Europe, Middle East, Africa, and Asia-Pacific, with the Americas contributing over half of total revenue.
Read more on GPRO →About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →
